95,050 total recalls in our database
Golden State Medical Supply
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
Labeling: Not Elsewhere Classified. This recall has been initiated due to mislabeling. The printed carton used in manufacturing both batches contained text for both 2% Xylocaine DENTAL and Articadent DENTAL. Xylocaine DENTAL is a trade name for Lidocaine HCL 2% and Epinephrine 1: 100,000 formulation, while Articadent DENTAL is a trade name for Articaine HCI 4% and Epinephrine 1 :100,000. The cartridges contained within the printed carton are labeled appropriately as Articadent DENTAL.
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
MALLINCKRODT PHARMACEUTICALS
Labeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being recalled because a sealed 60 ct. bottle contained only 8 mcg capsules, this incident is being considered as a labeling mix-up issue.
Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.
An investigation identified that the products were possibly manufactured from a different material than defined in the applicable specifications.
An investigation identified that the products were possibly manufactured from a different material than defined in the applicable specifications.
An investigation identified that the products were possibly manufactured from a different material than defined in the applicable specifications.
Kwart RetroInject Stent Set (Multi-Length) and Salle Intraoperative Pyeloplasty Stent Set Instructions for Use (IFU) did not include a warning for stent knotting.
An investigation identified that the products were possibly manufactured from a different material than defined in the applicable specifications.
An investigation identified that the products were possibly manufactured from a different material than defined in the applicable specifications.
Certain Auriga consoles may exhibit faster than normal power degradation due to a potential issue in the mechanical cooling system that could lead to a low power error (1301) being displayed on the screen. The console is designed to stop emitting laser pulses and enters a stand-by mode after a low power error message.
Potential for products to fail performance testing per the Instructions for Use (IFU) starting at 57 days after date of manufacturing. Expiration date is shortened from 7 months to 56 days.
An investigation identified that the products were possibly manufactured from a different material than defined in the applicable specifications.
Complaints received of sporadic erroneously elevated platelet results without flags or system messages. Thrombocytopenia may go unrecognized.
An investigation identified that the products were possibly manufactured from a different material than defined in the applicable specifications.
An investigation identified that the products were possibly manufactured from a different material than defined in the applicable specifications.
An investigation identified that the products were possibly manufactured from a different material than defined in the applicable specifications.
Polymer Technology Systems
Some lots of test strips do not fit tightly into the optical block, and may fall out during analysis, which could lead to an incorrect result being displayed
An investigation identified that the products were possibly manufactured from a different material than defined in the applicable specifications.